EpiCypher

EpiCypher is a bioscience company located in Durham, North Carolina, specializing in epigenetics and chromatin biology. A pioneer in the field, EpiCypher employs approximately 60 people and generates $8 million in annual revenue. EpiCypher develops transformative technologies and delivers superior products to researchers worldwide. The company's technologies and products are enabling studies that were not previously possible. EpiCypher's team of renowned chromatin researchers brings unique expertise and insight into chromatin biology and drug discovery, benefiting their customers in ways other companies cannot. EpiCypher's focus on epigenetics stems from its potential to revolutionize human health. Their products and technologies are designed to advance understanding of how epigenetic changes contribute to disease development and progression. For more information about EpiCypher, please visit their website at www.epicypher.com.